Olaratumab and Doxorubicin for the Treatment of Metastatic Soft Tissue Sarcoma: A Retrospective Case Series

Precision and Future Medicine
doi 10.23838/pfm.2019.00016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Sungkyunkwan University School of Medicine

Related search

Olaratumab in Soft Tissue Sarcoma – Current Status and Future Perspectives

European Journal of Cancer
Cancer ResearchOncology
2018English

Developments in the Management of Advanced Soft-Tissue Sarcoma &Ndash; Olaratumab in Context

OncoTargets and Therapy
OncologyPharmacology
2018English

Randomised Phase II Trial of Trofosfamide vs. Doxorubicin in Elderly Patients With Untreated Metastatic Soft-Tissue Sarcoma

European Journal of Cancer
Cancer ResearchOncology
2020English

Long-Term Follow-Up of Metastatic Clear Cell Sarcoma of Soft Tissue: A Case Report

Orthopedics & Traumatology
2012English

New Drugs and Combinations for the Treatment of Soft-Tissue Sarcoma: A Review

Cancer Management and Research
Oncology
2012English

Treatment of Pelvic Bone and Soft Tissue Sarcoma.

Orthopedics & Traumatology
1997English

Liver Resection for Metastatic Soft Tissue Sarcoma: An Analysis of Prognostic Factors

European Journal of Surgical Oncology
MedicineOncologySurgery
2011English

Erratum To: New Drug Developments for Patients With Metastatic Soft Tissue Sarcoma

Current Oncology Reports
Oncology
2012English

3. Angiofibroma of Soft Tissue: A Case Series

Pathology
Forensic MedicinePathology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy